Table:
begin	end	state
1	11	cytoplasmic
12	29	transmembrane
30	40	non-cytoplasmic
41	60	transmembrane
61	93	cytoplasmic
94	118	transmembrane
119	125	non-cytoplasmic
126	144	transmembrane
145	150	cytoplasmic
151	176	transmembrane
177	201	non-cytoplasmic
202	222	transmembrane
223	233	cytoplasmic
234	257	transmembrane
258	280	non-cytoplasmic
281	310	transmembrane
311	330	cytoplasmic
331	352	transmembrane
353	357	non-cytoplasmic
358	382	transmembrane
383	394	cytoplasmic
395	413	transmembrane
414	418	non-cytoplasmic
419	437	transmembrane
438	448	cytoplasmic
449	470	transmembrane
471	475	non-cytoplasmic

Input:
>AO356_05260
MPQPIEKLRLGALVALVVGSMIGGGIFSLPQNMAARADVGAVLIGWAITAVGMLTLAFVF
QTLANRKPELDSGVYAYAKAGFGDYMGFSSAWGYWISAWMGNVGYFVLLFSTLGYFFPVF
GQGNTPVAIACASLLLWAVHFLVLRGIKEAAFINLVTTIAKVVPLVMFIVIAAVAFKAEV
FTRDIWGEMNPDLGSVMDQVRHMMLVTVFVFIGIEGASVYSARAEKRADVGRATVIGFLG
VLALLVLVNVLSLGIMTQPVLAQLQNPSLAGVLEHIVGPWGALLISLGLAVSLLGALLSW
ALLCAEILYATARDKTMPAFLTKENANRAPVNALWLTNGMIQLFLLITLFSAGTYTSLIY
LASSMILVPYLWSAAYAVLLCARGETYGQASARRMKDLCIGGVALCYAVWLLYAGGVKYL
LLSALLYAPGVILFAQAKREQRQPLFTHVEKGVFACVMSGAGLAAYGLYSGFLAL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server